FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320486021> ?p ?o ?g. }

• W4320486021 endingPage "353" @default.
• W4320486021 startingPage "353" @default.
• W4320486021 abstract "The dose of supplemental vitamin D needed in infants born with serum 25-hydroxyvitamin D (25[OH]D) concentrations less than 50 nmol/L (ie, 20 ng/mL) is unclear.To determine whether a higher dose (1000 IU vs 400 IU per day) is required in infants born with 25(OH)D concentrations less than 50 nmol/L for bone mineral accretion across infancy.In this prespecified secondary analysis of a double-blinded randomized clinical trial, conducted from March 2016 to March 2019 in a single center in Greater Montreal, Quebec, Canada, a consecutive sample of 139 healthy term singletons were recruited from 866 infants screened for vitamin D status at birth. Data were analyzed from June 2021 to November 2022.Capillary blood was collected 24 to 36 hours after birth to measure serum total 25(OH)D concentrations. Infants with 25(OH)D concentrations less than 50 nmol/L were randomized to receive either 1000 IU or 400 IU per day of oral vitamin D3 supplementation from age 1 to 12 months. Infants with 25(OH)D concentrations of 50 nmol/L or greater formed a reference group.Measures at age 1, 3, 6, and 12 months were preplanned and included whole-body bone mineral content, lumbar spine bone mineral content, and bone mineral density using dual-energy x-ray absorptiometry, and serum 25(OH)D3 using liquid chromatography tandem mass spectrometry.Of 139 included infants, 81 (58.3%) were male, and the median (IQR) gestational age at birth was 39.6 (38.9-40.6) weeks. A total of 49 infants were included in the 1000 IU per day group, 49 infants in the 400 IU per day group, and 41 in the reference group. Mean (SD) whole-body bone mineral content was not different between trial groups over time (1000 IU per day, 173.09 [2.36] g; 400 IU per day, 165.94 [66.08] g). Similarly, no differences were observed in lumbar spine bone mineral content or density. Mean (SD) serum 25(OH)D3 concentrations were significantly higher in the 1000 IU per day group from age 3 to 12 months (3 months, 115.2 [35.3] nmol/L; 6 months, 121.6 [34.4] nmol/L; 12 months, 99.6 [28.8] nmol/L) compared with the 400 IU per day trial group (3 months, 77.4 [23.3] nmol/L; 6 months, 85.1 [18.6] nmol/L; 12 months, 82.3 [14.3] nmol/L).In this study, a higher dose of vitamin D supplementation in infants born with 25(OH)D concentrations less than 50 nmol/L did not present advantages to bone mass in infancy. This study supports a standard dose of 400 IU per day of vitamin D supplementation for breastfed infants in Montreal.ClinicalTrials.gov Identifier: NCT02563015." @default.
• W4320486021 created "2023-02-14" @default.
• W4320486021 creator A5001406504 @default.
• W4320486021 creator A5013272432 @default.
• W4320486021 creator A5013460050 @default.
• W4320486021 creator A5034272564 @default.
• W4320486021 creator A5038133566 @default.
• W4320486021 creator A5038178023 @default.
• W4320486021 creator A5038634249 @default.
• W4320486021 creator A5039775439 @default.
• W4320486021 creator A5055371936 @default.
• W4320486021 creator A5065423470 @default.
• W4320486021 creator A5065751179 @default.
• W4320486021 creator A5065928407 @default.
• W4320486021 creator A5080056341 @default.
• W4320486021 creator A5087277974 @default.
• W4320486021 date "2023-04-01" @default.
• W4320486021 modified "2023-10-01" @default.
• W4320486021 title "Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L" @default.
• W4320486021 cites W1513301338 @default.
• W4320486021 cites W171409896 @default.
• W4320486021 cites W1966633533 @default.
• W4320486021 cites W1976600426 @default.
• W4320486021 cites W2010947517 @default.
• W4320486021 cites W2015389128 @default.
• W4320486021 cites W2026047392 @default.
• W4320486021 cites W2041302995 @default.
• W4320486021 cites W2046143181 @default.
• W4320486021 cites W2055490615 @default.
• W4320486021 cites W2078999613 @default.
• W4320486021 cites W2112099358 @default.
• W4320486021 cites W2114059803 @default.
• W4320486021 cites W2149391245 @default.
• W4320486021 cites W2157219431 @default.
• W4320486021 cites W2164847969 @default.
• W4320486021 cites W2165275292 @default.
• W4320486021 cites W2165342913 @default.
• W4320486021 cites W2270170673 @default.
• W4320486021 cites W2275140877 @default.
• W4320486021 cites W247926508 @default.
• W4320486021 cites W2806792552 @default.
• W4320486021 cites W2807249591 @default.
• W4320486021 cites W2905053345 @default.
• W4320486021 cites W2990267369 @default.
• W4320486021 cites W3217294781 @default.
• W4320486021 cites W4224056100 @default.
• W4320486021 cites W4224297962 @default.
• W4320486021 cites W4242194139 @default.
• W4320486021 cites W4250875619 @default.
• W4320486021 doi "https://doi.org/10.1001/jamapediatrics.2022.5837" @default.
• W4320486021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36780180" @default.
• W4320486021 hasPublicationYear "2023" @default.
• W4320486021 type Work @default.
• W4320486021 citedByCount "3" @default.
• W4320486021 countsByYear W43204860212023 @default.
• W4320486021 crossrefType "journal-article" @default.
• W4320486021 hasAuthorship W4320486021A5001406504 @default.
• W4320486021 hasAuthorship W4320486021A5013272432 @default.
• W4320486021 hasAuthorship W4320486021A5013460050 @default.
• W4320486021 hasAuthorship W4320486021A5034272564 @default.
• W4320486021 hasAuthorship W4320486021A5038133566 @default.
• W4320486021 hasAuthorship W4320486021A5038178023 @default.
• W4320486021 hasAuthorship W4320486021A5038634249 @default.
• W4320486021 hasAuthorship W4320486021A5039775439 @default.
• W4320486021 hasAuthorship W4320486021A5055371936 @default.
• W4320486021 hasAuthorship W4320486021A5065423470 @default.
• W4320486021 hasAuthorship W4320486021A5065751179 @default.
• W4320486021 hasAuthorship W4320486021A5065928407 @default.
• W4320486021 hasAuthorship W4320486021A5080056341 @default.
• W4320486021 hasAuthorship W4320486021A5087277974 @default.
• W4320486021 hasBestOaLocation W43204860211 @default.
• W4320486021 hasConcept C124490489 @default.
• W4320486021 hasConcept C126322002 @default.
• W4320486021 hasConcept C140793950 @default.
• W4320486021 hasConcept C187212893 @default.
• W4320486021 hasConcept C2776541429 @default.
• W4320486021 hasConcept C2776886416 @default.
• W4320486021 hasConcept C2776940978 @default.
• W4320486021 hasConcept C2778376644 @default.
• W4320486021 hasConcept C2779234561 @default.
• W4320486021 hasConcept C2779740938 @default.
• W4320486021 hasConcept C54355233 @default.
• W4320486021 hasConcept C71924100 @default.
• W4320486021 hasConcept C86803240 @default.
• W4320486021 hasConceptScore W4320486021C124490489 @default.
• W4320486021 hasConceptScore W4320486021C126322002 @default.
• W4320486021 hasConceptScore W4320486021C140793950 @default.
• W4320486021 hasConceptScore W4320486021C187212893 @default.
• W4320486021 hasConceptScore W4320486021C2776541429 @default.
• W4320486021 hasConceptScore W4320486021C2776886416 @default.
• W4320486021 hasConceptScore W4320486021C2776940978 @default.
• W4320486021 hasConceptScore W4320486021C2778376644 @default.
• W4320486021 hasConceptScore W4320486021C2779234561 @default.
• W4320486021 hasConceptScore W4320486021C2779740938 @default.
• W4320486021 hasConceptScore W4320486021C54355233 @default.
• W4320486021 hasConceptScore W4320486021C71924100 @default.
• W4320486021 hasConceptScore W4320486021C86803240 @default.
• W4320486021 hasIssue "4" @default.

• next